Fig. 6

Viral load and survival rate predictions for various levels of drug efficacy and timing of treatment initiation, assuming no pharmacokinetic variability. Left: ε = 50% (eg, favipiravir), middle: ε = 90% (eg, GS-5734); right: ε = 99%. Dark blue: treatment initiation at D0, magenta: D2, light blue: D3, yellow: D4, green: D5, brown: D7. Results show the median of 1000 simulations